Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

837.00p
   
  • Change Today:
      10.50p
  • 52 Week High: 1,764.00p
  • 52 Week Low: 576.50p
  • Currency: UK Pounds
  • Shares Issued: 126.53m
  • Volume: 285,351
  • Market Cap: £1,059.03m
  • RiskGrade: 314
  • Beta: 1.53

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Key Personnel

CEO: Mark Crossley
CFO & Executive Director: Ryan Preblick
Chairman: Graham Hetherington
Independent Non-Executive Director: Mark Stejbach
Independent Non-Executive Director: David E. Wheadon
Independent Non-Executive Director: Peter Bains
Independent Non-Executive Director: Barbara Ryan
Independent Non-Executive Director: Jo Le Couilliard
Independent Non-Executive Director: Keith Humphreys
Senior Independent Director: Juliet Thompson
Non-Executive Dir: Jerome Lande

Contact Details

Address: 234 Bath Road, Slough, Berkshire, United Kingdom, SL1 4EE
Website: http://www.Indivior.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 250, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:INDVL
ISIN: GB00BN4HT335

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 837.00p
Change Today 10.50p
% Change 1.27 %
52 Week High 1,764.00p
52 Week Low 576.50p
Volume 285,351
Shares Issued 126.53m
Market Cap £1,059.03m
Beta 1.53
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
56.93% below the market average56.93% below the market average56.93% below the market average56.93% below the market average56.93% below the market average
16% below the sector average16% below the sector average16% below the sector average16% below the sector average16% below the sector average
Price Trend
66.02% above the market average66.02% above the market average66.02% above the market average66.02% above the market average66.02% above the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Income Not Available
Growth
54.56% above the market average54.56% above the market average54.56% above the market average54.56% above the market average54.56% above the market average
Sector averageSector averageSector averageSector averageSector average

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:26 0 @ 829.00p
16:28 42 @ 830.50p
16:28 89 @ 830.50p
16:28 211 @ 830.50p
16:28 219 @ 830.50p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page